Utility of 5-ALA for resection of CNS tumours other than high-grade gliomas: a protocol for a systematic review
Introduction 5-aminolevulinic acid (5-ALA) is a proagent developed for fluorescent-guided surgery for high-grade glioma patients associated with a significant increase in resection conferring survival. 5-ALA was shown to penetrate the blood–brain barrier accumulating in malignant glioma cells with h...
Saved in:
Main Authors: | Michael D Jenkinson, Ashwin Venkatesh, Colin Watts, Michael T C Poon, Victoria Wykes, Stephen John Price, Puneet Plaha, Georgios Solomou, Melissa Gough, Conor S Gillespie, Aref-Ali Gharooni, Waqqas Patel |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/7/e056059.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fluorescence-Guided Resection of Malignant Glioma with 5-ALA
by: Sadahiro Kaneko, et al.
Published: (2016-01-01) -
CroALa
by: Neven Jovanović
Published: (2012-02-01) -
THE CONCEPT OF ‘ALA BỤ ALA’: A SIGNAL FOR IGBO EXTINCTION
by: CYPRIAN CHIDOZIE EZE, et al.
Published: (2023-12-01) -
Role of Microglia in CNS Autoimmunity
by: Tobias Goldmann, et al.
Published: (2013-01-01) -
Immune Privilege as an Intrinsic CNS Property: Astrocytes Protect the CNS against T-Cell-Mediated Neuroinflammation
by: Ulrike Gimsa, et al.
Published: (2013-01-01)